GBT
AGN

Grove Bank & Trust’s Allergan plc AGN Stock Holding History

Grove Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,056
Closed -$173K – 497
2017
Q4 		$173K Sell
1,056
-252
-19% -$45.2K 0.08% 171
2017
Q3 		$268K Sell
1,308
-99
-7% -$23K 0.13% 136
2017
Q2 		$342K Buy
1,407
+919
+188% +$216K 0.22% 108
2017
Q1 		$117K Sell
488
-112
-19% -$26.1K 0.1% 147
2016
Q4 		$126K Sell
600
-1,374
-70% -$285K 0.1% 137
2016
Q3 		$455K Buy
1,974
+268
+16% +$65.5K 0.39% 62
2016
Q2 		$394K Buy
1,706
+344
+25% +$79.3K 0.35% 66
2016
Q1 		$365K Buy
1,362
+110
+9% +$31.5K 0.33% 66
2015
Q4 		$391K Buy
+1,252
New +$373K 0.35% 64

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Grove Bank & Trust's AGN Position: Q1 2018 in Review

Grove Bank & Trust sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,056 shares — an estimated $173K sold.

Grove Bank & Trust first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $455K in Q3 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Grove Bank & Trust reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Grove Bank & Trust sold 1,056 Allergan plc shares in Q1 2018, an estimated $173K.
  • Grove Bank & Trust first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
  • Grove Bank & Trust's Allergan plc position peaked at $455K in Q3 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Grove Bank & Trust's 13F filing for Q1 2018, filed 7 May 2018.